This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
protein
product name :
Human NADE (aa 8-107) Control Fragment Recombinant Protein
catalog :
RP-92231
quantity :
100 uL
price :
US 259.00
product information
Product Type :
Protein
Product Name :
Human NADE (aa 8-107) Control Fragment Recombinant Protein
Catalog # :
RP-92231
Quantity :
100 uL
Price :
US 259.00
Clonality :
Recombinant
Purity :
purified
Reactivity :
Human
Applications :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Species :
Human
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
May be a signaling adapter molecule involved in p75NTR-mediated apoptosis induced by NGF. Plays a role in zinc-triggered neuronal death. May play an important role in the pathogenesis of neurogenetic diseases.
Format :
Liquid
Applications w/Dilutions :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Aliases :
AL033356; Bex; Bex3; brain expressed X-linked 3; brain-expressed X-linked protein 3; Brain-expressed X-linked protein 3 homolog; DXS6984E; DXWsu67e; Gcap27; granule cell antiserum positive 27; HGR74; Nade; nerve growth factor receptor (TNFRSF16) associated protein 1; nerve growth factor receptor associated protein 1; nerve growth factor receptor-associated protein 1; Ngfrap1; ovarian granulosa cell 13.0 kDa protein HGR74; p75NTR-associated cell death executor; protein BEX3; rBex3; RP13-349O20.1
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments